| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.
|
Endocrinology
|
1995
|
3.17
|
|
2
|
Inhibition of histamine-, pentagastrin-, and insulin-stimulated canine gastric secretion by pure "gastric inhibitory polypeptide".
|
Gastroenterology
|
1972
|
2.05
|
|
3
|
Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats.
|
Diabetes
|
2001
|
1.38
|
|
4
|
Preparation of highly active enterogastrone.
|
Can J Physiol Pharmacol
|
1969
|
1.30
|
|
5
|
Gastric inhibitory polypeptide. Its physiologic release and insulinotropic action in the dog.
|
Diabetes
|
1975
|
1.25
|
|
6
|
Further purification of a polypeptide demonstrating enterogastrone activity.
|
J Physiol
|
1970
|
1.10
|
|
7
|
The insulinotropic action of gastric inhibitory polypeptide in the perfused isolated rat pancreas.
|
Endocrinology
|
1976
|
1.08
|
|
8
|
Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs.
|
J Biol Chem
|
2000
|
1.01
|
|
9
|
Gastrin secretion from human antral G cells in culture.
|
Gastroenterology
|
1990
|
1.00
|
|
10
|
Improved glucose tolerance in rats treated with the dipeptidyl peptidase IV (CD26) inhibitor Ile-thiazolidide.
|
Metabolism
|
1999
|
0.97
|
|
11
|
Gastric inhibitory polypeptide release from a tumor-derived cell line.
|
Am J Physiol
|
1995
|
0.97
|
|
12
|
Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin.
|
Endocrinology
|
1999
|
0.96
|
|
13
|
Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties.
|
Endocrinology
|
1995
|
0.94
|
|
14
|
Investigation of glucose-dependent insulinotropic polypeptide-(1-42) and glucagon-like peptide-1-(7-36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. A novel kinetic approach.
|
J Biol Chem
|
1996
|
0.93
|
|
15
|
Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas.
|
Endocrinology
|
1978
|
0.92
|
|
16
|
Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP).
|
Biochim Biophys Acta
|
2001
|
0.91
|
|
17
|
Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose.
|
Diabet Med
|
2000
|
0.90
|
|
18
|
The insulinotropic action of gastric inhibitory polypeptide.
|
Can J Physiol Pharmacol
|
1975
|
0.89
|
|
19
|
Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats.
|
Diabetes
|
2002
|
0.89
|
|
20
|
Morphological and functional alterations to a sub-group of regulatory peptides in human pancreas and intestine after jejuno-ileal bypass.
|
Int J Obes Relat Metab Disord
|
1993
|
0.89
|
|
21
|
Effect of aging and diabetes on the enteroinsular axis.
|
J Gerontol A Biol Sci Med Sci
|
2001
|
0.89
|
|
22
|
Gastric inhibitory polypeptide stimulated secretion of somatostatinlike immunoreactivity from the stomach: inhibition by acetylcholine or vagal stimulation.
|
Can J Physiol Pharmacol
|
1981
|
0.88
|
|
23
|
A new pathway for glucose-dependent insulinotropic polypeptide (GIP) receptor signaling: evidence for the involvement of phospholipase A2 in GIP-stimulated insulin secretion.
|
J Biol Chem
|
2001
|
0.88
|
|
24
|
Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
|
Endocrinology
|
1997
|
0.88
|
|
25
|
Effect of glucagon-like peptide 1 on non-insulin-mediated glucose uptake in the elderly patient with diabetes.
|
Diabetes Care
|
2001
|
0.87
|
|
26
|
A multiparameter study on the action of preparations containing cholecystokinin-pancreozymin.
|
Scand J Gastroenterol
|
1970
|
0.86
|
|
27
|
Atherogenesis in two strains of obese rats. The fatty Zucker and LA/N-corpulent.
|
Atherosclerosis
|
1988
|
0.86
|
|
28
|
Metabolism of glucagon by dipeptidyl peptidase IV (CD26).
|
Regul Pept
|
2001
|
0.85
|
|
29
|
Characterization of the carboxyl-terminal domain of the rat glucose-dependent insulinotropic polypeptide (GIP) receptor. A role for serines 426 and 427 in regulating the rate of internalization.
|
J Biol Chem
|
1999
|
0.84
|
|
30
|
Long-term effectiveness of oral vanadyl sulphate in streptozotocin-diabetic rats.
|
Diabetologia
|
1993
|
0.83
|
|
31
|
The effect of somatostatin on release and insulinotropic action of gastric inhibitory polypeptide.
|
Can J Physiol Pharmacol
|
1975
|
0.83
|
|
32
|
The effect of massive small bowel resection (MSBR) and small intestinal bypass (JIB) in the rat on the enteroinsular axis.
|
Regul Pept
|
1983
|
0.83
|
|
33
|
Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion.
|
Am J Physiol
|
1995
|
0.82
|
|
34
|
Glucose-dependent insulinotropic action of cholecystokinin octapeptide in the isolated perfused rat pancreas.
|
Digestion
|
1983
|
0.82
|
|
35
|
Meal-frequency effects on plasma hormone concentrations and cholesterol synthesis in humans.
|
Am J Clin Nutr
|
1993
|
0.82
|
|
36
|
The Xenopus proglucagon gene encodes novel GLP-1-like peptides with insulinotropic properties.
|
Proc Natl Acad Sci U S A
|
1997
|
0.81
|
|
37
|
GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro.
|
Regul Pept
|
1997
|
0.81
|
|
38
|
The effect of dietary restriction on gastrin secretion in the obese Zucker rat.
|
Int J Obes
|
1990
|
0.81
|
|
39
|
GIP receptors and signal-transduction mechanisms.
|
Acta Physiol Scand
|
1996
|
0.81
|
|
40
|
Gastric inhibitory polypeptide and hyperinsulinemia in the Zucker (fa/fa) rat: a developmental study.
|
Int J Obes
|
1985
|
0.79
|
|
41
|
Effect of jejunoileal bypass in the rat on the enteroinsular axis.
|
Regul Pept
|
1982
|
0.79
|
|
42
|
Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat.
|
Diabetes
|
1984
|
0.79
|
|
43
|
The insulinotropic region of gastric inhibitory polypeptide; fragment analysis suggests the bioactive site lies between residues 19 and 30.
|
Can J Physiol Pharmacol
|
1996
|
0.79
|
|
44
|
Effect of massive small bowel resection on components of the peptidergic innervation of the rat small intestine.
|
Digestion
|
1990
|
0.78
|
|
45
|
Role of glucose in chronic desensitization of isolated rat islets and mouse insulinoma (betaTC-3) cells to glucose-dependent insulinotropic polypeptide.
|
J Endocrinol
|
2000
|
0.78
|
|
46
|
Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes.
|
J Gerontol A Biol Sci Med Sci
|
2001
|
0.78
|
|
47
|
Gastric inhibitory polypeptide and glucagon-like peptide-1(7-36) amide exert similar effects on somatostatin secretion but opposite effects on gastrin secretion from the rat stomach.
|
Can J Physiol Pharmacol
|
1994
|
0.78
|
|
48
|
Release of gastric inhibitory polypeptide from cultured canine endocrine cells.
|
Am J Physiol
|
1994
|
0.78
|
|
49
|
Anatomical relationship between neuropeptide-containing fibers and efferent vagal neurons projecting to the rat corpus.
|
Regul Pept
|
1991
|
0.77
|
|
50
|
Actions of GIP.
|
Peptides
|
1981
|
0.77
|
|
51
|
Enkephalinergic control of somatostatin secretion from the perfused rat stomach.
|
Can J Physiol Pharmacol
|
1983
|
0.77
|
|
52
|
Effects of low and high dose administration of bis(maltolato)oxovanadium(IV) on fa/fa Zucker rats.
|
Can J Physiol Pharmacol
|
1996
|
0.77
|
|
53
|
Analogs of glucose-dependent insulinotropic polypeptide with increased dipeptidyl peptidase IV resistance.
|
Adv Exp Med Biol
|
2000
|
0.76
|
|
54
|
Feedback regulation of glucose-dependent insulinotropic polypeptide (GIP) secretion by insulin in conscious rats.
|
Regul Pept
|
1994
|
0.76
|
|
55
|
Effect of substance P on somatostatin release from the isolated perfused rat stomach.
|
Gastroenterology
|
1985
|
0.76
|
|
56
|
Adrenergic control of rat gastric somatostatin and gastrin release.
|
Scand J Gastroenterol
|
1983
|
0.76
|
|
57
|
Physiology and pathophysiology of GIP.
|
Adv Exp Med Biol
|
1978
|
0.76
|
|
58
|
The effect of jejunoileal bypass (JIB) in the obese Zucker rat on a sub-group of enteroendocrine cells.
|
Int J Obes
|
1987
|
0.76
|
|
59
|
Cleavage of a gastric inhibitory polypeptide with cyanogen bromide and the physiological action of the C-terminal fragment.
|
J Physiol
|
1970
|
0.76
|
|
60
|
Meal frequency influences circulating hormone levels but not lipogenesis rates in humans.
|
Metabolism
|
1995
|
0.76
|
|
61
|
Influence of a perpetual-daylight Arctic environment on periodicity in human cholesterol synthesis.
|
Arctic Med Res
|
1995
|
0.75
|
|
62
|
The physiology and pathophysiology of gastric inhibitory polypeptide (GIP) and motilin.
|
Verh Dtsch Ges Inn Med
|
1974
|
0.75
|
|
63
|
The effect of total parenteral nutrition (TPN) on the enteroinsular axis in the rat.
|
Regul Pept
|
1985
|
0.75
|
|
64
|
The effect of theophylline on the actions of pancreozymin and secretin.
|
Experientia
|
1970
|
0.75
|
|
65
|
Isolation of a murine glucose-dependent insulinotropic polypeptide (GIP) cDNA from a tumor cell line (STC6-14) and quantification of glucose-induced increases in GIP mRNA.
|
Biochim Biophys Acta
|
1996
|
0.75
|
|
66
|
Effect of cholecystokinin, secretin, and gastric inhibitory polypeptide on insulin release from the isolated perfused rat pancreas.
|
Can J Physiol Pharmacol
|
1979
|
0.75
|
|
67
|
Altered glucose dependence of glucagon-like peptide I(7-36)-induced insulin secretion from the Zucker (fa/fa) rat pancreas.
|
Diabetes
|
1995
|
0.75
|
|
68
|
Insulin response of cultured islets from diabetic and nondiabetic BB rats.
|
Metabolism
|
1992
|
0.75
|
|
69
|
The gastrointestinal peptides and nutrition.
|
Can J Physiol Pharmacol
|
1983
|
0.75
|
|
70
|
Expression of recombinant human glucose-dependent insulinotropic polypeptide in Escherichia coli by sequence-specific proteolysis of a protein A fusion protein.
|
Peptides
|
1991
|
0.75
|
|
71
|
The effect of total parenteral nutrition (TPN) on gastrin release in the rat.
|
Regul Pept
|
1987
|
0.75
|
|
72
|
Adrenergic modulation of gastric somatostatin release in rats.
|
FEBS Lett
|
1980
|
0.75
|
|
73
|
Adrenergic and cholinergic interactions in rat gastric somatostatin and gastrin release.
|
Digestion
|
1982
|
0.75
|
|
74
|
The effect of total parenteral nutrition in the rat on a sub-group of enteroendocrine cells.
|
Regul Pept
|
1985
|
0.75
|
|
75
|
A rapid, sensitive, and easy-to-perform solid phase insulin radioimmunoassay.
|
Life Sci
|
1992
|
0.75
|
|
76
|
Kinetic analysis of enzymatic and nonenzymatic degradation of peptides by MALDI-TOFMS.
|
Methods Mol Biol
|
2000
|
0.75
|
|
77
|
Interaction of gastric inhibitory polypeptide and arginine with glucose in the perfused pancreas of rats treated with triiodothyronine.
|
Can J Physiol Pharmacol
|
1982
|
0.75
|
|
78
|
Glucagon-like peptide-1 (7-37) augments insulin release in elderly patients with diabetes.
|
Diabetes Care
|
2001
|
0.75
|
|
79
|
Gastrin release from isolated perfused rat stomach after vagotomy.
|
Am J Physiol
|
1984
|
0.75
|
|
80
|
Inhibition of bombesin-stimulated gastrin release from isolated canine G cells by bombesin antagonists.
|
Can J Physiol Pharmacol
|
1989
|
0.75
|
|
81
|
Hiroshima-like neutrons from A-bomb replica: physical basis for their use in biological experiments.
|
Radiat Res
|
1991
|
0.75
|
|
82
|
Absence of a relationship between immunoreactive-gastrin and somatostatin-like immunoreactivity secretion in the perfused rat stomach.
|
Regul Pept
|
1981
|
0.75
|